TP53 and cancer: Interestingly, previous work has suggested that targeted inhibition of spindle assembly checkpoint may re-sensitize TP53-deficient cancer cells to chemotherapeutic drugs64, offering a way to treat TP53-altered tumors with conventional chemotherapy.